Center-Authored Papers

Filters: Author is Karuna, Shelly T  [Clear All Filters]
2013
Fuchs JD, Sobieszczyk ME, Madenwald T, Grove D, Karuna ST, Andrasik M, Sherwat A, Broder G, Mayer K, Koblin B et al..  2013.  Intentions to use pre-exposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.. Journal of acquired immune deficiency syndromes (1999). Abstract
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD et al..  2013.  Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.. The New England journal of medicine. Abstract
Andrasik MP, Karuna ST, Nebergall M, Koblin BA, Kublin JG.  2013.  Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: A qualitative study exploring HVTN staff perspectives.. Vaccine. 31(40):4398-405. Abstract
2014
Lemos MP, Lama JR, Karuna ST, Fong Y, Montano SM, Ganoza C, Gottardo R, Sanchez J, McElrath MJ.  2014.  The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier.. PloS one. 9(9):e108954. Abstract
2015
Huang Y, Karuna ST, Janes H, Frahm N, Nason M, Edlefsen PT, Kublin JG, Corey L, McElrath MJ, Gilbert PB.  2015.  Use of placebos in Phase 1 preventive HIV vaccine clinical trials.. Vaccine. 33(6):749-52. Abstract
2016
Lama JR, Karuna ST, Grant SP, Swann EM, Ganoza C, Segura P, Montano SM, Lacherre M, De Rosa SC, Buchbinder S et al..  2016.  Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.. PloS one. 11(8):e0160487. Abstract
Siskind RL, Andrasik M, Karuna ST, Broder GB, Collins C, Liu A, Lucas JP, Harper GW, Renzullo PO.  2016.  Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.. Journal of acquired immune deficiency syndromes (1999). 72 Suppl 3:S243-7. Abstract